Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brain Tumours”

4,259 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,259 results

Not applicableLooking for participantsNCT06474533
What this trial is testing

Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm

Who this might be right for
Intracranial Neoplasm
Thomas Hope 199
Not applicableLooking for participantsNCT05954858
What this trial is testing

Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma

Who this might be right for
Glioma, MalignantGlioblastomaGlioblastoma Multiforme+4 more
Northwell Health 32
Large-scale testing (Phase 3)Ended earlyNCT05328908
What this trial is testing

Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Bristol-Myers Squibb 770
Not applicableStudy completedNCT02537106
What this trial is testing

A Comparison of the Effect of 1.5 Versus 3% NaCl on Brain Relaxation and Microcirculation

Who this might be right for
Brain Tumors
University Hospital Hradec Kralove 100
Not applicableStudy completedNCT02261649
What this trial is testing

Impact of Cerebellar Mass Resection on Pain Processing

Who this might be right for
Cerebellar Neoplasm
Dana-Farber Cancer Institute 24
Early research (Phase 1)Study completedNCT04264143
What this trial is testing

CED of MTX110 Newly Diagnosed Diffuse Midline Gliomas

Who this might be right for
Diffuse Intrinsic Pontine GliomaDiffuse Pontine and Thalamic GliomasDiffuse Midline Glioma
Luca Szalontay 9
Very early researchLooking for participantsNCT05996432
What this trial is testing

Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy

Who this might be right for
Head and Neck Squamous Cell CarcinomaBrain Metastases
Vanderbilt-Ingram Cancer Center 48
Testing effectiveness (Phase 2)Ended earlyNCT04610684
What this trial is testing

Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases

Who this might be right for
Small-cell Lung CancerBrain Metastases
Jeffrey Clarke 3
Not applicableLooking for participantsNCT00599092
What this trial is testing

Pituitary Tumor Surveillance: Pathogenic Correlation

Who this might be right for
Pituitary Tumor
Cedars-Sinai Medical Center 1,250
Early research (Phase 1)Study completedNCT01975116
What this trial is testing

P28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors

Who this might be right for
Teratoid Tumor, AtypicalChoroid Plexus NeoplasmsAnaplastic Astrocytoma+7 more
Pediatric Brain Tumor Consortium 18
Early research (Phase 1)Study completedNCT00503204
What this trial is testing

Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour

Who this might be right for
Recurrent GlioblastomaBrain Tumor
AstraZeneca 20
Testing effectiveness (Phase 2)Study completedNCT00002931
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer

Who this might be right for
Brain and Central Nervous System TumorsExtragonadal Germ Cell TumorOvarian Cancer+2 more
City of Hope Medical Center 48
Testing effectiveness (Phase 2)Study completedNCT00619112
What this trial is testing

Temozolomide in Treating Patients With Recurrent High-Grade Glioma

Who this might be right for
Recurrent Central Nervous System Neoplasm
University of California, San Francisco 60
Testing effectiveness (Phase 2)UnknownNCT00492687
What this trial is testing

Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
San Diego Pacific Oncology & Hematology Associates 80
Testing effectiveness (Phase 2)Study completedNCT00006358
What this trial is testing

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 44
Early research (Phase 1)Ended earlyNCT00734526
What this trial is testing

Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma

Who this might be right for
GlioblastomaGliosarcoma
M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)Ended earlyNCT00814463
What this trial is testing

Stereotactic Radiosurgery After Surgery in Treating Patients With Brain Metastases

Who this might be right for
Metastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
Duke University 1
Not applicableStudy completedNCT06417333
What this trial is testing

A Smart-wrist Band Connected Mobile Application for the Assessment and Management of Dementia Symptoms

Who this might be right for
Dementia, Mild
Muğla Sıtkı Koçman University 60
Not applicableStudy completedNCT03746392
What this trial is testing

Project to Improve Communication About Serious Illness - Pilot Study

Who this might be right for
Malignant NeoplasmLeukemia, Lymphocytic, Chronic, B-CellLung Disease Chronic+7 more
University of Washington 150
Testing effectiveness (Phase 2)Study completedNCT01931098
What this trial is testing

Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab

Who this might be right for
GlioblastomaGlioblastoma MultiformeGliosarcoma+2 more
National Cancer Institute (NCI) 35
Load More Results